Quintiles Transnational Holdings Inc., marked an incline in its revenue, between 2008 and 2012, at a CAGR of 7.3% and EBITDA at 13.9%. The Quintiles IPO, the largest multinational biopharmaceutical development and commercial outsourcing service provider, the case was set in December 2012-April 2013, at a time when the founder Dennis Gillings owned many of the firms.
Four private equity firms, including Temasek Life Sciences, 3i Capital, TPG Capital, and Bain Capital after this was acquired in a management, started acquisition in 2003 and a subsequent acquisition in 2008.
The founders of the private equity firm, five years after the second acquisition, evaluating the various strategic alternatives, to optimize their position, such as Capital restructuring with a different dividend, IPO, or M&A sale to the strategic or financial buyers.
Quintiles IPO Case Solution Case Study Solution
This case asks students to put in the shoes of an associate, in the lead investment bank, who works for Quintiles and asks them to determine an IPO strategy, process, worth, and potential consequences based on the given information in the case.
Related Case Solutions & Analyses:
Engro Chemicals Pakistan Limited – Business Disaster Overcome
Global Airlines
Alibaba’s IPO Dilemma: Hong Kong or New York?
Longbow Capital Partners
Poseidon Carlsbad: Desalination and the San Diego County Water Authority
A Better Way of Managing Major Risks: Strategic Risk Management
Waste Management, Inc.
Dozier Industries (A)
The Toshiba Accounting Scandal: How Corporate Governance Failed
Designing Performance Metrics at GoDaddy
